Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHospital Ambroise Paré Paris

About this trial

Septic shock remains a leading cause of mortality in intensive care, and while fluid resuscitation (FR) is a cornerstone of early management, its benefit-risk balance is highly variable. Excessive fluid administration can cause venous congestion and organ dysfunction, while insufficient resuscitation risks hypoperfusion. Current strategies often rely on fluid responsiveness (i.e., increased cardiac output after fluids), but this does not guarantee improved outcomes, particularly if congestion ensues.

This prospective, multicenter, observational study aims to assess the clinical impact of FR in septic shock patients who are fluid responsive. The primary objective is to evaluate changes in tissue perfusion and venous congestion markers following FR. Patients will be categorized into four response profiles based on the presence or absence of perfusion improvement and congestion worsening.

Secondary objectives include exploring the prognostic implications of each profile (organ dysfunction, mortality), identifying pre-FR predictors of adverse responses, evaluating changes in congestion markers after passive leg raising (PLR), and performing phenotypic clustering and mediation analyses.

Eligible patients are adults with septic shock requiring vasopressors and mechanical ventilation, with confirmed fluid responsiveness via echocardiography. Each patient will undergo standardized pre- and post-FR assessments, including cardiac ultrasound, Doppler of hepatic/portal veins (VeXUS), CVP, perfusion markers, and blood gases.

Data on SOFA scores, organ support duration, and 28-day mortality will be collected. Approximately 170 patients will be enrolled across five ICUs experienced in advanced hemodynamic monitoring. Statistical analyses will include multivariate modeling, clustering, ROC curves, and mediation analyses.

By identifying phenotypes of fluid-responsive but fluid-intolerant patients, the study aims to refine fluid management strategies and improve outcomes through more personalized care in septic shock.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Septic shock (sepsis-3 criteria)

Under mechanical ventilation

Central venous catheter in the superior vena cava territory and arterial catheter in place

Response to fluid resuscitation as per standard definition (i.e., an increase in cardiac output >10% assessed by subaortic velocity time integral [VTI] using echocardiography)

Disqualifiers

Patient under 18 years of age

Lack of social security coverage / adult under legal protection

Pregnant woman

Inability to obtain non-opposition consent

Trial population

Patients in septic shock, defined according to the Sepsis-3 criteria (7), who are under mechanical ventilation, have a central venous catheter in the superior vena cava territory and an arterial catheter, present with hypotension requiring vasopressor support and hyperlactatemia, and demonstrate a response to fluid resuscitation as per standard definition (i.e., an increase in cardiac output \>10% assessed by subaortic velocity time integral \[VTI\] using echocardiography).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Echography

    Diagnostic test

    An exhaustive echography will be performed to determine fluid responsiveness (using a passive leg raising test and cardiac output measurement by left ventricular outflow tract velocity time integral)

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Comparison of septic shock patients based on a four-category classification based on 30 minutes to 1 hour after fluid resuscitation

Comparison of septic shock patients based on a four-category classification

Time frame
30 minutes to 1 hour after fluid resuscitation

Secondary outcomes

1

Evolution of the cardiovascular, respiratory, and renal SOFA scores at 24 hours after fluid resuscitation and on Day 28.

Time frame
24 hours after fluid resuscitation and on Day 28.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: